...
首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Angiotensin II type 2 receptors and nitric oxide sustain oxygenation in the clipped kidney of early Goldblatt hypertensive rats.
【24h】

Angiotensin II type 2 receptors and nitric oxide sustain oxygenation in the clipped kidney of early Goldblatt hypertensive rats.

机译:血管紧张素II 2型受体和一氧化氮在早期Goldblatt高血压大鼠的肾脏肾脏中维持氧合作用。

获取原文
获取原文并翻译 | 示例

摘要

Angiotensin-converting enzyme inhibitors (ACEIs) decrease the glomerular filtration rate and renal blood flow in the clipped kidneys of early 2-kidney, 1-clip Goldblatt hypertensive rats, but the consequences for oxygenation are unclear. We investigated the hypothesis that angiotensin II type 1 or angiotensin II type 2 receptors or NO synthase mediate renal oxygenation responses to ACEI. Three weeks after left renal artery clipping, kidney function, oxygen (O(2)) use, renal blood flow, renal cortical blood flow, and renal cortical oxygen tension (Po(2)) were measured after acute administration of an ACEI (enalaprilat) and after acute administration of ACEI following acute administration of an angiotensin II type 1 or angiotensin II type 2 receptor blocker (candesartan or PD-123,319) or an NO synthase blocker (N(G)-nitro-L-arginine methyl ester with control of renal perfusion pressure) and compared with mechanical reduction in renal perfusion pressure to the levels after ACEI. The basal renal cortical Po(2) of clipped kidneys was significantly lower than contralateral kidneys (35+/-1 versus 51+/-1 mm Hg; n=40 each). ACEI lowered renal venous Po(2), cortical Po(2), renal blood flow, glomerular filtration rate, and cortical blood flow and increased the renal vascular resistance in the clipped kidney, whereas mechanical reduction in renal perfusion pressure was ineffective. PD-123,319 and N(G)-nitro-L-arginine methyl ester, but not candesartan, reduced the Po(2) of clipped kidneys and blocked the fall in Po(2) with acute ACEI administration. In conclusion, oxygen availability in the clipped kidney is maintained by angiotensin II generation, angiotensin II type 2 receptors, and NO synthase. This discloses a novel mechanism whereby angiotensin can prevent hypoxia in a kidney challenged with a reduced perfusion pressure.
机译:血管紧张素转换酶抑制剂(ACEIs)可降低早期2肾1夹Goldblatt高血压大鼠的肾脏肾脏中的肾小球滤过率和肾血流量,但尚不清楚氧合的后果。我们调查了血管紧张素II 1型或血管紧张素II 2型受体或NO合酶介导ACEI的肾脏氧合反应的假说。急性给予ACEI(依那普利拉)后,测量左肾动脉夹闭三周后的肾功能,氧气(O(2))使用量,肾血流量,肾皮质血流量和肾皮质氧张力(Po(2))。 )并在急性给予ACEI后急性给予血管紧张素II 1型或血管紧张素II 2型受体阻滞剂(坎地沙坦或PD-123,319)或NO合酶阻滞剂(N(G)-硝基-L-精氨酸甲酯)肾灌注压)和机械降低肾灌注压至ACEI后的水平进行比较。截断肾脏的基底肾皮质Po(2)显着低于对侧肾脏(35 +/- 1对51 +/- 1 mm Hg;每个n = 40)。 ACEI降低了肾静脉Po(2),皮质Po(2),肾血流量,肾小球滤过率和皮质血流量,并增加了被截断肾脏的肾脏血管阻力,而机械性降低肾脏灌注压力无效。 PD-123,319和N(G)-硝基-L-精氨酸甲酯,但不是坎地沙坦,可减少受急性ACEI​​管理的肾脏的Po(2)并阻止Po(2)的下降。总之,通过血管紧张素II的产生,血管紧张素II的2型受体和NO合酶,可以维持肾脏中的氧气供应。这公开了一种新颖的机制,通过该机制,血管紧张素可以预防以降低的灌注压挑战的肾脏的缺氧。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号